Cargando…

Classical and Alternative Activation of Rat Microglia Treated with Ultrapure Porphyromonas gingivalis Lipopolysaccharide In Vitro

The possible relationship between periodontal disease resulting from the infection of gingival tissue by the Gram-negative bacterium Porphyromonas gingivalis (P. gingivalis) and the development of neuroinflammation remains under investigation. Recently, P. gingivalis lipopolysaccharide (LPS) was rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Memedovski, Zylfi, Czerwonka, Evan, Han, Jin, Mayer, Joshua, Luce, Margaret, Klemm, Lucas C., Hall, Mary L., Mayer, Alejandro M. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290770/
https://www.ncbi.nlm.nih.gov/pubmed/32438602
http://dx.doi.org/10.3390/toxins12050333
_version_ 1783545754060587008
author Memedovski, Zylfi
Czerwonka, Evan
Han, Jin
Mayer, Joshua
Luce, Margaret
Klemm, Lucas C.
Hall, Mary L.
Mayer, Alejandro M. S.
author_facet Memedovski, Zylfi
Czerwonka, Evan
Han, Jin
Mayer, Joshua
Luce, Margaret
Klemm, Lucas C.
Hall, Mary L.
Mayer, Alejandro M. S.
author_sort Memedovski, Zylfi
collection PubMed
description The possible relationship between periodontal disease resulting from the infection of gingival tissue by the Gram-negative bacterium Porphyromonas gingivalis (P. gingivalis) and the development of neuroinflammation remains under investigation. Recently, P. gingivalis lipopolysaccharide (LPS) was reported in the human brain, thus suggesting it might activate brain microglia, a cell type participating in neuroinflammation. We tested the hypothesis of whether in vitro exposure to ultrapure P. gingivalis LPS may result in classical and alternative activation phenotypes of rat microglia, with the concomitant release of cytokines and chemokines, as well as superoxide anion (O(2)(−)), thromboxane B(2) (TXB(2)), and matrix metalloprotease-9 (MMP-9). After an 18-h exposure of microglia to P. gingivalis LPS, the concentration-dependent responses were the following: 0.1–100 ng/mL P. gingivalis LPS increased O(2)(−) generation, with reduced inflammatory mediator generation; 1000–10,000 ng/mL P. gingivalis LPS generated MMP-9, macrophage inflammatory protein 1α (MIP-1α/CCL3), macrophage inflammatory protein-2 (MIP-2/CXCL2) release and significant O(2)(−) generation; 100,000 ng/mL P. gingivalis LPS sustained O(2)(−) production, maintained MMP-9, tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) release, and triggered elevated levels of MIP-1α/CCL3, MIP-2/CXCL2, and cytokine-induced neutrophil chemoattractant 1 (CINC-1/CXCL-1), with a very low release of lactic dehydrogenase (LDH). Although P. gingivalis LPS was less potent than Escherichia coli (E. coli) LPS in stimulating TXB(2), MMP-9, IL-6 and interleukin 10 (IL-10) generation, we observed that it appeared more efficacious in enhancing the release of O(2)(−), TNF-α, MIP-1α/CCL3, MIP-2/CXCL2 and CINC-1/CXCL-1. Our results provide support to our research hypothesis because an 18-h in vitro stimulation with ultrapure P. gingivalis LPS resulted in the classical and alternative activation of rat brain microglia and the concomitant release of cytokines and chemokines.
format Online
Article
Text
id pubmed-7290770
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72907702020-06-17 Classical and Alternative Activation of Rat Microglia Treated with Ultrapure Porphyromonas gingivalis Lipopolysaccharide In Vitro Memedovski, Zylfi Czerwonka, Evan Han, Jin Mayer, Joshua Luce, Margaret Klemm, Lucas C. Hall, Mary L. Mayer, Alejandro M. S. Toxins (Basel) Article The possible relationship between periodontal disease resulting from the infection of gingival tissue by the Gram-negative bacterium Porphyromonas gingivalis (P. gingivalis) and the development of neuroinflammation remains under investigation. Recently, P. gingivalis lipopolysaccharide (LPS) was reported in the human brain, thus suggesting it might activate brain microglia, a cell type participating in neuroinflammation. We tested the hypothesis of whether in vitro exposure to ultrapure P. gingivalis LPS may result in classical and alternative activation phenotypes of rat microglia, with the concomitant release of cytokines and chemokines, as well as superoxide anion (O(2)(−)), thromboxane B(2) (TXB(2)), and matrix metalloprotease-9 (MMP-9). After an 18-h exposure of microglia to P. gingivalis LPS, the concentration-dependent responses were the following: 0.1–100 ng/mL P. gingivalis LPS increased O(2)(−) generation, with reduced inflammatory mediator generation; 1000–10,000 ng/mL P. gingivalis LPS generated MMP-9, macrophage inflammatory protein 1α (MIP-1α/CCL3), macrophage inflammatory protein-2 (MIP-2/CXCL2) release and significant O(2)(−) generation; 100,000 ng/mL P. gingivalis LPS sustained O(2)(−) production, maintained MMP-9, tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) release, and triggered elevated levels of MIP-1α/CCL3, MIP-2/CXCL2, and cytokine-induced neutrophil chemoattractant 1 (CINC-1/CXCL-1), with a very low release of lactic dehydrogenase (LDH). Although P. gingivalis LPS was less potent than Escherichia coli (E. coli) LPS in stimulating TXB(2), MMP-9, IL-6 and interleukin 10 (IL-10) generation, we observed that it appeared more efficacious in enhancing the release of O(2)(−), TNF-α, MIP-1α/CCL3, MIP-2/CXCL2 and CINC-1/CXCL-1. Our results provide support to our research hypothesis because an 18-h in vitro stimulation with ultrapure P. gingivalis LPS resulted in the classical and alternative activation of rat brain microglia and the concomitant release of cytokines and chemokines. MDPI 2020-05-19 /pmc/articles/PMC7290770/ /pubmed/32438602 http://dx.doi.org/10.3390/toxins12050333 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Memedovski, Zylfi
Czerwonka, Evan
Han, Jin
Mayer, Joshua
Luce, Margaret
Klemm, Lucas C.
Hall, Mary L.
Mayer, Alejandro M. S.
Classical and Alternative Activation of Rat Microglia Treated with Ultrapure Porphyromonas gingivalis Lipopolysaccharide In Vitro
title Classical and Alternative Activation of Rat Microglia Treated with Ultrapure Porphyromonas gingivalis Lipopolysaccharide In Vitro
title_full Classical and Alternative Activation of Rat Microglia Treated with Ultrapure Porphyromonas gingivalis Lipopolysaccharide In Vitro
title_fullStr Classical and Alternative Activation of Rat Microglia Treated with Ultrapure Porphyromonas gingivalis Lipopolysaccharide In Vitro
title_full_unstemmed Classical and Alternative Activation of Rat Microglia Treated with Ultrapure Porphyromonas gingivalis Lipopolysaccharide In Vitro
title_short Classical and Alternative Activation of Rat Microglia Treated with Ultrapure Porphyromonas gingivalis Lipopolysaccharide In Vitro
title_sort classical and alternative activation of rat microglia treated with ultrapure porphyromonas gingivalis lipopolysaccharide in vitro
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290770/
https://www.ncbi.nlm.nih.gov/pubmed/32438602
http://dx.doi.org/10.3390/toxins12050333
work_keys_str_mv AT memedovskizylfi classicalandalternativeactivationofratmicrogliatreatedwithultrapureporphyromonasgingivalislipopolysaccharideinvitro
AT czerwonkaevan classicalandalternativeactivationofratmicrogliatreatedwithultrapureporphyromonasgingivalislipopolysaccharideinvitro
AT hanjin classicalandalternativeactivationofratmicrogliatreatedwithultrapureporphyromonasgingivalislipopolysaccharideinvitro
AT mayerjoshua classicalandalternativeactivationofratmicrogliatreatedwithultrapureporphyromonasgingivalislipopolysaccharideinvitro
AT lucemargaret classicalandalternativeactivationofratmicrogliatreatedwithultrapureporphyromonasgingivalislipopolysaccharideinvitro
AT klemmlucasc classicalandalternativeactivationofratmicrogliatreatedwithultrapureporphyromonasgingivalislipopolysaccharideinvitro
AT hallmaryl classicalandalternativeactivationofratmicrogliatreatedwithultrapureporphyromonasgingivalislipopolysaccharideinvitro
AT mayeralejandroms classicalandalternativeactivationofratmicrogliatreatedwithultrapureporphyromonasgingivalislipopolysaccharideinvitro